+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Baby Infant Formula Market by Product Type, Ingredients and Distribution Channel: Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 176 Pages
  • May 2022
  • Region: United States
  • Allied Market Research
  • ID: 5781790
The U.S. baby infant formula market was valued at $3,889.0 million in 2020, and is projected to reach $6,784.7 million by 2030, registering a CAGR of 8.6% from 2021 to 2030.

Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.

The rise in the participation of women in the labor force in the U.S. acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and the growth of the middle-class population have led to changes in lifestyle.

The middle-class population is more affluent and can afford to spend more on their children, thus driving market growth. In addition, consumer perception of the high nutritional content in the infant formula supplements the market growth. Furthermore, an increase in health consciousness among consumers boosts the demand for infant formula having a high content of protein, minerals, and vitamins. However, concerns related to food safety and the decline in the birth rate are anticipated to hamper the market growth. On the contrary, a shift in preference for organic infant formulas is expected to offer new avenues for manufacturers.

The U.S. baby infant formula market is segmented on the basis of product type, ingredient, distribution channel, and source. Depending on product type, the market is segregated into infant milk, follow-on milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others. By source, it is classified into regular, organic, milk with HMO, goat milk, plant-based formula, and others.

The major players analyzed for the U.S. Baby Infant Formula Market are Abott Laboratories, Alra Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.

Key benefits for the stakeholder

  • The report provides an in-depth analysis of the current trends, drivers, and dynamics of the U.S. baby infant formula market to elucidate the prevailing opportunities and potential investment pockets.
  • It offers qualitative trends and quantitative analysis for the period of 2020-2030 to assist stakeholders to understand the market scenario.
  • In-depth analysis of the key segments demonstrates the trending types across the U.S.
  • Competitive intelligence of the industry highlights the business practices followed by key players across the U.S. and the prevailing market opportunities.
  • The key players are profiled along with their strategies and developments to understand the competitive outlook of the industry.

Key Market Segments

By Product Type

  • Infant milk
  • Follow-on-milk
  • Specialty baby milk
  • Growing-up milk

By Ingredient

  • Carbohydrate
  • Fat
  • Protein
  • Minerals
  • Vitamins
  • others

By Distribution Channel

  • Hypermarkets
  • Supermarkets
  • Pharmacy/medical stores
  • Specialty stores
  • Hard discounter stores
  • others

By Source

  • Regular
  • Organic
  • Milk with HMO
  • Goat milk
  • Plant-based formula
  • Others

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for the stakeholder
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary Research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key finding of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five force analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. Threat of substitutes
3.3.5. Intensity of competitive rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in number of women participation in labor force
3.4.1.2. High nutritional content of infant formula
3.4.2. Restraint
3.4.2.1. Concerns related to food safety
3.4.2.2. Government initiatives to promote breastfeeding
3.4.3. Opportunity
3.4.3.1. Shift in preference toward organic baby food & drinks
3.4.3.2. Developments in technology result in emergence of new products
3.4.3.3. Extensive research on prebiotic and probiotics in baby food
3.5. Value chain analysis
3.6. Impact of key regulation
3.7. U.S. Infant Formula Market: COVID-19 Impact Analysis
CHAPTER 4: U.S. BABY INFANT FORMULA MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Infant milk
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Follow-on milk
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Specialty baby milk
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast
4.5. Growing-up milk
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
CHAPTER 5: U.S. BABY INFANT FORMULA MARKET, BY INGRIDIENT
5.1. Overview
5.1.1. Market size and forecast
5.2. Carbohydrate
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.3. Fat
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.4. Protein
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.5. Minerals
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast
5.6. Vitamins
5.6.1. Key market trends, growth factors, and opportunities
5.6.2. Market size and forecast
5.7. Others
5.7.1. Key market trends, growth factors, and opportunities
5.7.2. Market size and forecast
CHAPTER 6: U.S. BABY INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hypermarkets
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.3. Supermarkets
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.4. Pharmacy/medical stores
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast
6.5. Specialty stores
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast
6.6. Hard discounter stores
6.6.1. Key market trends, growth factors, and opportunities
6.6.2. Market size and forecast
6.7. Others
6.7.1. Key market trends, growth factors, and opportunities
6.7.2. Market size and forecast
CHAPTER 7: U.S. BABY INFANT FORMULA MARKET, BY SOURCE
7.1. Overview
7.1.1. Market size and forecast
7.2. Regular
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast
7.3. Organic
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast
7.4. Milk with HMO
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast
7.5. Goat Milk
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast
7.6. Plant-based formula
7.6.1. Key market trends, growth factors, and opportunities
7.6.2. Market size and forecast
7.7. Others
7.7.1. Key market trends, growth factors, and opportunities
7.7.2. Market size and forecast
CHAPTER 8: COMPETITION LANDSCAPE
8.1. Top winning strategies
8.2. Product mapping
8.3. Competitive dashboard
8.4. Competitive heat map
8.5. Key developments
8.5.1. Acquisition
8.5.2. Business Expansion
8.5.3. Product Launch
8.5.4. Agreement
CHAPTER 9: COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1. Company snapshot
9.1.2. Operating business segments
9.1.3. Product portfolio
9.1.4. Distribution channel
9.1.5. R&D expenditure
9.1.6. Business performance
9.2. ARLA FOODS AMBA
9.2.1. Company snapshot
9.2.2. Operating business segments
9.2.3. Product portfolio
9.2.4. Distribution channel
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. AUSSIE BUBS, Inc
9.3.1. Company snapshot
9.3.2. Product portfolio
9.3.3. Distribution channel
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. BOBBIE
9.4.1. Company snapshot
9.4.2. Product portfolio
9.4.3. Distribution channel
9.4.4. Key strategic moves and developments
9.5. CAMPBELL SOUPS COMPANY
9.5.1. Company snapshot
9.5.2. Operating business segments
9.5.3. Product portfolio
9.5.4. Distribution channel
9.5.5. R&D expenditure
9.5.6. Business performance
9.6. DANA DAIRY GROUP LTD.
9.6.1. Company snapshot
9.6.2. Product portfolio
9.6.3. Distribution channel
9.6.4. Key strategic moves and developments
9.7. DANONE SA
9.7.1. Company snapshot
9.7.2. Operating business segments
9.7.3. Product portfolio
9.7.4. Distribution channel
9.7.5. Business performance
9.8. D-SIGNSTORE
9.8.1. Company snapshot
9.8.2. Product portfolio
9.8.3. Distribution channel
9.9. ELSE NUTRITION HOLDINGS INC.
9.9.1. Company snapshot
9.9.2. Product portfolio
9.9.3. Distribution channel
9.9.4. Key strategic moves and developments
9.10. HIPP GmbH & CO. VERTRIEB KG
9.10.1. Company snapshot
9.10.2. Product portfolio
9.10.3. Distribution channel
9.11. HOLLE BABY FOOD AG
9.11.1. Company snapshot
9.11.2. Product portfolio
9.11.3. Distribution channel
9.12. KABRITA USA
9.12.1. Company snapshot
9.12.2. Product portfolio
9.12.3. Distribution channel
9.13. NATURE’S ONE, LLC
9.13.1. Company snapshot
9.13.2. Product portfolio
9.13.3. Distribution channel
9.13.4. Key strategic moves and developments
9.14. NESTLE S.A.
9.14.1. Company snapshot
9.14.2. Operating business segments
9.14.3. Product portfolio
9.14.4. Distribution channel
9.14.5. Business performance
9.14.6. Key strategic moves and developments
9.15. RECKITT BENCKISER GROUP PLC
9.15.1. Company snapshot
9.15.2. Operating business segments
9.15.3. Product portfolio
9.15.4. Distribution channel
9.15.5. R&D Expenditure
9.15.6. Business performance
9.16. THE HAIN CELESTIAL GROUP, INC.
9.16.1. Company snapshot
9.16.2. Product portfolio
9.16.3. Distribution channel
9.16.4. R&D Expenditure
9.16.5. Business performance
List of Tables
TABLE 01. U.S. BABY INFANT FORMULA MARKET VALUE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. U.S. BABY INFANT FORMULA MARKET VOLUME, BY PRODUCT TYPE, 2020-2030 (KILOTON)
TABLE 03. U.S. BABY INFANT MILK MARKET VALUE, 2020-2030 ($MILLION)
TABLE 04. U.S. BABY INFANT MILK MARKET VOLUME, 2020-2030 (KILOTON)
TABLE 05. U.S. FOLLOW-ON MILK MARKET VALUE, 2020-2030 ($MILLION)
TABLE 06. U.S. FOLLOW-ON MILK MARKET VOLUME , 2020-2030 (KILOTON)
TABLE 07. U.S. SPECIALTY BABY MILK MARKET VALUE, 2020-2030 ($MILLION)
TABLE 08. U.S. SPECIALTY BABY MILK MARKET VOLUME, 2020-2030 (KILOTON)
TABLE 09. U.S. BABY INFANT FORMULA MARKET VALUE, BY POINT OF SALE, 2020-2030 ($MILLION)
TABLE 10. U.S. GROWING-UP MILK MARKET VALUE, 2020-2030 ($MILLION)
TABLE 11. U.S. GROWING-UP MILK MARKET VOLUME, 2020-2030 (KILOTON)
TABLE 12. U.S. BABY INFANT FORMULA MARKET VALUE, BY INGREDIENT, 2020-2030 ($MILLION)
TABLE 13. U.S. BABY INFANT FORMULA MARKET VALUE FOR CARBOHYDRATE, 2020-2030 ($MILLION)
TABLE 14. U.S. BABY INFANT FORMULA MARKET VALUE FOR FAT, 2020-2030 ($MILLION)
TABLE 15. U.S. BABY INFANT FORMULA MARKET VALUE FOR PROTEIN, 2020-2030 ($MILLION)
TABLE 16. U.S. BABY INFANT FORMULA MARKET VALUE FOR MINERALS, 2020-2030 ($MILLION)
TABLE 17. U.S. BABY INFANT FORMULA MARKET VALUE FOR VITAMINS, 2020-2030 ($MILLION)
TABLE 18. U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2020-2030 ($MILLION)
TABLE 19. U.S. BABY INFANT FORMULA MARKET VALUE, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 20. U.S. BABY INFANT FORMULA MARKET VALUE FOR HYPERMARKET, 2020-2030 ($MILLION)
TABLE 21. U.S. BABY INFANT FORMULA MARKET VALUE FOR SUPERMARKET, 2020-2030 ($MILLION)
TABLE 22. U.S. BABY INFANT FORMULA MARKET VALUE FOR PHARMACY/MEDICAL STORES, 2020-2030 ($MILLION)
TABLE 23. U.S. BABY INFANT FORMULA MARKET VALUE FOR SPECIALTY STORES, 2020-2030 ($MILLION)
TABLE 24. U.S. BABY INFANT FORMULA MARKET VALUE FOR HARD DISCOUNTER STORES, 2020-2030 ($MILLION)
TABLE 25. U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2020-2030 ($MILLION)
TABLE 26. U.S. BABY INFANT FORMULA MARKET VALUE, BY SOURCE, 2020-2030 ($MILLION)
TABLE 27. U.S. BABY INFANT FORMULA MARKET VALUE FOR REGULAR, 2020-2030 ($MILLION)
TABLE 28. U.S. BABY INFANT FORMULA MARKET VALUE FOR ORGANIC, 2020-2030 ($MILLION)
TABLE 29. U.S. BABY INFANT FORMULA MARKET VALUE FOR MILK WITH HMO, 2020-2030 ($MILLION)
TABLE 30. U.S. BABY INFANT FORMULA MARKET VALUE FOR GOAT MILK, 2020-2030 ($MILLION)
TABLE 31. U.S. BABY INFANT FORMULA MARKET VALUE FOR PLANT-BASED FORMULA, 2020-2030 ($MILLION)
TABLE 32. U.S. BABY INFANT FORMULA MARKET VALUE FOR OTHERS, 2020-2030 ($MILLION)
TABLE 33. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 34. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 35. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 36. ABBOTT LABORATORIES: DISTRIBUTION CHANNEL
TABLE 37. ABBOTT LABORATORIES: R&D EXPENDITURE, 2019-2021 ($MILLION)
TABLE 38. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
TABLE 39. ARLA FOODS AMBA: COMPANY SNAPSHOT
TABLE 40. ARLA FOODS AMBA: OPERATING SEGMENTS
TABLE 41. ARLA FOODS AMBA: PRODUCT PORTFOLIO
TABLE 42. ARLA FOODS AMBA: DISTRIBUTION CHANNEL
TABLE 43. ARLA FOODS: NET SALES, 2019-2021 ($MILLION)
TABLE 44. AUSSIE BUBS, INC: COMPANY SNAPSHOT
TABLE 45. AUSSIE BUBS, INC: PRODUCT PORTFOLIO
TABLE 46. AUSSIE BUBS, INC: DISTRIBUTION CHANNEL
TABLE 47. AUSSIE BUBS, INC: NET SALES, 2018-2020 ($MILLION)
TABLE 48. KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 49. BOBBIE: COMPANY SNAPSHOT
TABLE 50. BOBBIE: PRODUCT PORTFOLIO
TABLE 51. BOBBIE: DISTRIBUTION CHANNEL
TABLE 52. CAMPBELL SOUP COMPANY: COMPANY SNAPSHOT
TABLE 53. CAMPBELL SOUP COMPANY: OPERATING SEGMENTS
TABLE 54. CAMPBELL SOUP COMPANY: PRODUCT PORTFOLIO
TABLE 55. CAMPBELL SOUP COMPANY: DISTRIBUTION CHANNEL
TABLE 56. CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2019-2021 ($MILLION)
TABLE 57. CAMPBELL SOUP COMPANY: NET SALES, 2019-2021 ($MILLION)
TABLE 58. DANA DAIRY GROUP LTD.: COMPANY SNAPSHOT
TABLE 59. DANA DAIRY GROUP LTD.: PRODUCT PORTFOLIO
TABLE 60. DANA DAIRY GROUP LTD.: DISTRIBUTION CHANNEL
TABLE 61. DANONE SA: COMPANY SNAPSHOT
TABLE 62. DANONE SA: OPERATING SEGMENTS
TABLE 63. DANONE SA: PRODUCT PORTFOLIO
TABLE 64. DANONE SA: DISTRIBUTION CHANNEL
TABLE 65. DANONE SA: NET SALES, 2018-2020 ($MILLION)
TABLE 66. D-SIGNSTORE: COMPANY SNAPSHOT
TABLE 67. D-SIGNSTORE: PRODUCT PORTFOLIO
TABLE 68. D-SIGNSTORE: DISTRIBUTION CHANNEL
TABLE 69. ELSE NUTRITION HOLDINGS INC.: COMPANY SNAPSHOT
TABLE 70. ELSE NUTRITION HOLDINGS INC.: PRODUCT PORTFOLIO
TABLE 71. ELSE NUTRITION HOLDINGS INC.: DISTRIBUTION CHANNEL
TABLE 72. HIPP GMBH & CO. VERTRIEB KG: COMPANY SNAPSHOT
TABLE 73. HIPP GMBH & CO. VERTRIEB KG: PRODUCT PORTFOLIO
TABLE 74. HIPP GMBH & CO. VERTRIEB KG: DISTRIBUTION CHANNEL
TABLE 75. HOLLE BABY FOOD AG: COMPANY SNAPSHOT
TABLE 76. HOLLE BABY FOOD AG: PRODUCT PORTFOLIO
TABLE 77. HOLLE BABY FOOD AG: DISTRIBUTION CHANNEL
TABLE 78. KABRITA USA: COMPANY SNAPSHOT
TABLE 79. KABRITA USA: PRODUCT PORTFOLIO
TABLE 80. KABRITA USA: DISTRIBUTION CHANNEL
TABLE 81. NATURE’S ONE, LLC: COMPANY SNAPSHOT
TABLE 82. NATURE’S ONE, LLC: PRODUCT PORTFOLIO
TABLE 83. NATURE’S ONE, LLC: DISTRIBUTION CHANNEL
TABLE 84. NESTLE S. A: COMPANY SNAPSHOT
TABLE 85. NESTLE S. A: OPERATING SEGMENTS
TABLE 86. NESTLE S. A: PRODUCT PORTFOLIO
TABLE 87. NESTLE S. A: DISTRIBUTION CHANNEL
TABLE 88. NESTLE S. A: NET SALES, 2019-2021 ($MILLION)
TABLE 89. RECKITT BENCKISER GROUP PLC.: COMPANY SNAPSHOT
TABLE 90. RECKITT BENCKISER GROUP PLC: OPERATING SEGMENTS
TABLE 91. RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
TABLE 92. RECKITT BENCKISER GROUP PLC: DISTRIBUTION CHANNEL
TABLE 93. RECKITT BENCKISER GROUP PLC: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 94. RECKITT BENCKISER GROUP PLC: NET SALES, 2018-2020 ($MILLION)
TABLE 95. THE HAIN CELESTIAL GROUP, INC.: COMPANY SNAPSHOT
TABLE 96. THE HAIN CELESTIAL GROUP, INC: PRODUCT PORTFOLIO
TABLE 97. THE HAIN CELESTIAL GROUP, INC: DISTRIBUTION CHANNEL
TABLE 98. THE HAIN CELESTIAL INC.: R&D EXPENDITURE, 2016-2018 ($MILLION)
TABLE 99. THE HAIN CELESTIAL INC.: NET SALES, 2019-2021 ($MILLION)
List of Figures
FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. U.S. BABY INFANT FORMULA MARKET SNAPSHOT, 2020-2030
FIGURE 03. TOP INVESTMENT POCKETS, 2020
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09. MARKET DYNAMIC ANALYSIS
FIGURE 10. IMPACT OF KEY REGULATION: U.S. BABY INFANT FORMULA MARKET
FIGURE 11. U.S. BABY INFANT FORMULA MARKET SHARE, BY PRODUCT TYPE, 2020 (%)
FIGURE 12. U.S. BABY INFANT FORMULA MARKET SHARE, BY INGRIDIENT, 2020 (%)
FIGURE 13. U.S. BABY INFANT FORMULA MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (%)
FIGURE 14. U.S. BABY INFANT FORMULA MARKET SHARE, BY SOURCE, 2020 (%)
FIGURE 15. TOP WINNING STRATEGIES, BY YEAR, 2019-2021*
FIGURE 16. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021* (%)
FIGURE 17. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 18. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 19. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 20. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 21. ABBOTT LABORATORIES: R&D EXPENDITURE, 2019-2021 ($MILLION)
FIGURE 22. ABBOTT LABORATORIES: NET SALES, 2019-2021 ($MILLION)
FIGURE 23. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 24. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 25. ARLA FOODS AMBA: NET SALES, 2019-2021 ($MILLION)
FIGURE 26. ARLA FOODS AMBA: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 27. ARLA FOODS AMBA: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 28. AUSSIE BUBS, INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 29. AUSSIE BUBS, INC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30. CAMPBELL SOUP COMPANY: R&D EXPENDITURE, 2019-2021 ($MILLION)
FIGURE 31. CAMPBELL SOUP COMPANY: NET SALES, 2019-2021 ($MILLION)
FIGURE 32. CAMPBELL SOUP COMPANY: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 33. CAMPBELL SOUP COMPANY: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 34. DANONE SA: NET SALES, 2018-2020 ($MILLION)
FIGURE 35. DANONE SA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36. NESTLE S. A: NET SALES, 2019-2021 ($MILLION)
FIGURE 37. NESTLE S. A: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 38. RECKITT BENCKISER GROUP PLC: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 39. RECKITT BENCKISER GROUP PLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 40. RECKITT BENCKISER GROUP PLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 41. RECKITT BENCKISER GROUP PLC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 42. THE HAIN CELESTIAL INC.: R&D EXPENDITURE, 2019-2021 ($MILLION)
FIGURE 43. THE HAIN CELESTIAL INC.: NET SALES, 2019-2021 ($MILLION)
FIGURE 44. THE HAIN CELESTIAL INC.: REVENUE SHARE BY REGION, 2021 (%)

Executive Summary

U.S. Baby Infant Formula Market is Expected to Reach $6,784.7 Million by 2030.

Baby infant formula is a uniquely prepared nutritious substitute for breast milk. It is specially designed to provide necessary nutrients to infants to have a healthy development. It is available in the form of powder, liquid, or ready-to-feed form. Moreover, it is incorporated with a rich combination of proteins, carbohydrates, fats, vitamins, and minerals. This formula is applicable as a complete or partial substitute for breast milk.

The U.S. Baby Infant Formula market is segmented on the basis of product type, ingredient distribution channel, and source. By product type, the market is divided into infant milk, follow-on milk, specialty baby milk, and others. By ingredient, the market is classified into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, the market is fragmented into hypermarkets, supermarkets, pharmacy/ medical stores, specialty stores, hard discounters’ stores, and others. By source, the market is segregated into regular, organic, milk with HMO, goat milk, plant-based formula, and others.

The food & beverage sector is one of the key sectors meeting the needs of the growing population. Moreover, the rise in the female working population has eventually resulted in a surge in demand for baby infant formula. According to the U.S. Bureau of Statistics, the working women population has increased from 57.1% in 2018 to 57.5% in 2020. Most mothers rebound to their professional schedule immediately after the birth of the child. Consequently, the imbalance of the breastfeeding schedule results in the adoption of convenient alternatives such as baby infant formula. Owing to the rise in the population of working women, the demand for baby infant formula has accelerated. This is attributed to easy preparedness along with the easy storage capacity of baby infant formula. It serves as a convenient alternative for busy parents as the infant formula lasts longer than breastmilk. In addition, the rise in unhealthy lifestyles along with medical conditions results in insufficient milk production. In some situations, infants are prescribed for the consumption of formula. These factors have accelerated the demand for baby infant formula in the U.S.

The regulatory bodies have been alerting the benefits of breastfeeding. This has resulted in the implementation of initiatives to promote and support breastfeeding. It is considered the absolute way of providing healthy growth to an infant. Many promotional activities are done by policymakers and health activists. The consideration of breast milk as the best suitable diet for infants hampers the market of baby infant formula in the U.S. The organizations that support breastfeeding uplift parents to cook baby foods for babies after the age of six months. Furthermore, many sectors provide extra maternity leave to support breastfeeding. Other workplace supports such as breastfeeding breaks and the presence of private spaces for nursing mothers have encouraged breastfeeding activity among parents.

Prebiotics and probiotics are utilized to maintain the healthy being of the guts. They promote the growth of beneficial bacteria. Moreover, infant formula providers have included the use of prebiotics and probiotics in infant formula, after extensive R&D activities. In addition, major key players are supporting the use of these microorganisms owing to their nourishing and functional properties. Prebiotics and probiotics are categorized as GRAS (generally regarded as safe) by the FDA and are promoted as an ingredient in commercial infant formulas. For instance, many key players have introduced Hipp Dutch Stage 1 (0-6 Months) Organic Combiotic Infant Milk Formula, Kendamil Stage 1 (0-6 Months) Organic Baby Formula: (prebiotics), Earth’s Best Organic Toddler (prebiotics), Earth’s Best Organic Dairy (prebiotics) by the Hain Celestial, and Similac Probiotic Tri-Blend Supplement Powder. These factors are expected to provide growth opportunities for the industry leaders to boost their product sales in the U.S. baby infant formula market in the upcoming years.

The major players analyzed for the U.S. Baby Infant Formula Market are Abbott Laboratories, Arla Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.

Key Findings of the Study

  • By product type, the infant milk segment was the highest revenue contributor to the market, with $2,204 million in 2020, and is estimated to reach $3,894.5 million by 2030, with a CAGR of 8.8%.
  • By ingredient, the carbohydrate segment was the highest revenue contributor to the market, with $2,195.0 million in 2020, and is estimated to reach $3,789.3 million by 2030, with a CAGR of 8.4%.
  • Depending on the distribution channel, the Hypermarket segment was the highest revenue contributor to the market, with $1,241 million in 2020, and is estimated to reach $2,078.1 million by 2030, with a CAGR of 7.9%.
  • By source, regular was the highest revenue contributor, accounting for $1,412.5 million in 2020, and is estimated to reach $2,293.3 million by 2030, with a CAGR of 7.5%.

Companies Mentioned

  • Abbott Laboratories
  • Arla Foods
  • Bobbie
  • Campbell Soups Company
  • Dana Dairy Group, Ltd.
  • Danone S.A.
  • D-Signstore
  • Else Nutrition Holdings, Inc.
  • Hipp GmbH & Co.
  • Vertrieb KG
  • Holle Baby Food AG
  • Kabrita USA, Nature’s One, LLC.
  • Nestle S.A.
  • Reckitt Benckiser Group Plc.
  • The Hain Celestial Group, Inc.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...